IRTC Profile
iRhythm Technologies, Inc. is a pioneering digital healthcare company specializing in advanced ambulatory electrocardiogram (ECG) monitoring solutions for patients at risk of arrhythmias. The company’s flagship product, the Zio service, is a comprehensive ambulatory cardiac monitoring solution that integrates a wire-free, patch-based wearable biosensor with a sophisticated cloud-based data analytics platform. This innovative approach allows physicians to continuously monitor patients' heart rhythms and accurately diagnose arrhythmias, significantly improving patient care and outcomes.
The Zio service includes two primary devices: the Zio XT and Zio AT monitors. Both are single-use, wire-free, and patch-based biosensors designed to record patients' heartbeats and ECG data over extended periods. These monitors are equipped with advanced algorithms and sensors to capture high-resolution cardiac data, enabling detailed analysis and facilitating early detection of potential cardiac issues. The wireless, patch-based design enhances patient comfort and compliance, while the cloud-based analytics platform provides actionable insights to healthcare providers.
In addition to its core products, iRhythm Technologies has established a development collaboration agreement with Verily Life Sciences LLC. This partnership aims to advance next-generation atrial fibrillation (AFib) screening, detection, and monitoring products. The collaboration is focused on leveraging cutting-edge technologies to enhance the accuracy and efficiency of AFib diagnosis and management, reflecting iRhythm’s commitment to innovation in cardiac care.
Founded in 2006 and headquartered in San Francisco, California, iRhythm Technologies has positioned itself as a leader in digital cardiac monitoring. The company’s integration of wearable biosensors with advanced data analytics is revolutionizing how arrhythmias are detected and managed. By continuing to develop and refine its technology, iRhythm Technologies is set to make a significant impact on the future of cardiac healthcare, improving patient outcomes and supporting physicians with state-of-the-art diagnostic tools.
|
